<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32462286</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-8798</ISSN><JournalIssue CitedMedium="Internet"><Volume>165</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Archives of virology</Title><ISOAbbreviation>Arch Virol</ISOAbbreviation></Journal><ArticleTitle>Single B cells reveal the antibody responses of rhesus macaques immunized with an inactivated enterovirus D68 vaccine.</ArticleTitle><Pagination><StartPage>1777</StartPage><EndPage>1789</EndPage><MedlinePgn>1777-1789</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00705-020-04676-6</ELocationID><Abstract><AbstractText>Enterovirus D68 (EV-D68) infection may cause severe respiratory system manifestations in pediatric populations. Because of the lack of an effective preventive vaccine or specific therapeutic drug for this infection, the development of EV-D68-specific vaccines and antibodies has become increasingly important. In this study, we prepared an experimental EV-D68 vaccine inactivated by formaldehyde and found that the serum of rhesus macaques immunized with the inactivated EV-D68 vaccine exhibited potent neutralizing activity against EV-D68 virus in vitro. Subsequently, the antibody-mediated immune response of B cells elicited by the inactivated vaccine was evaluated in a rhesus monkey model. The binding activity, in vitro neutralization activity, and sequence properties of 28 paired antibodies from the rhesus macaques' EV-D68-specific single memory B cells were analyzed, and the EV-D68 VP1-specific antibody group was found to be the main constituent in vivo. Intriguingly, we also found a synergistic effect among the E15, E18 and E20 monoclonal antibodies from the rhesus macaques. Furthermore, we demonstrated the protective efficacy of maternal antibodies in suckling C57BL/6 mice. This study provides valuable information for the future development of EV-D68 vaccines.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Huiwen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, 650118, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zening</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, 650118, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bingxiang</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Heng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, 650118, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, 650118, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, 650118, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Dongpei</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, 650118, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, 650118, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jinxi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, 650118, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qiongwen</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, 650118, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, 650118, China. sunming@imbcams.com.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Longding</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-6430-5677</Identifier><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, 650118, China. longdingl@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Beijing, China. longdingl@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2016-I2M-1-014</GrantID><Agency>CAMS Innovation Fund for Medical Sciences</Agency><Country/></Grant><Grant><GrantID>3332020066</GrantID><Agency>Basic scientific research funding of national colleges and universities</Agency><Country/></Grant><Grant><GrantID>2018IA044</GrantID><Agency>Yunnan Province Major Project of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Austria</Country><MedlineTA>Arch Virol</MedlineTA><NlmUniqueID>7506870</NlmUniqueID><ISSNLinking>0304-8608</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015164">Vaccines, Inactivated</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000917" MajorTopicYN="N">Antibody Formation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008253" MajorTopicYN="N">Macaca mulatta</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015164" MajorTopicYN="N">Vaccines, Inactivated</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>All authors declare that the have no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32462286</ArticleId><ArticleId IdType="pmc">PMC8851307</ArticleId><ArticleId IdType="doi">10.1007/s00705-020-04676-6</ArticleId><ArticleId IdType="pii">10.1007/s00705-020-04676-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Imamura T, Oshitani H. Global reemergence of enterovirus D68 as an important pathogen for acute respiratory infections. Rev Med Virol. 2015;25(2):102&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4407910</ArticleId><ArticleId IdType="pubmed">25471236</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, et al. A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA. Lancet. 2015;385(9978):1662&#x2013;1671.</Citation><ArticleIdList><ArticleId IdType="pubmed">25638662</ArticleId></ArticleIdList></Reference><Reference><Citation>Pariani E, et al. Letter to the editor: need for a European network for enterovirus D68 surveillance after detections of EV-D68 of the new B3 lineage in Sweden and Italy, 2016. Euro Surveill. 2017;22:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5404488</ArticleId><ArticleId IdType="pubmed">28106530</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu QB, et al. Detection of enterovirus 68 as one of the commonest types of enterovirus found in patients with acute respiratory tract infection in China. J Med Microbiol. 2014;63(Pt 3):408&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pubmed">24324030</ArticleId></ArticleIdList></Reference><Reference><Citation>Fall A, et al. Low circulation of subclade A1 enterovirus D68 strains in senegal during 2014 North America Outbreak. Emerg Infect Dis. 2019;25(7):1404&#x2013;1407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6590772</ArticleId><ArticleId IdType="pubmed">31211670</ArticleId></ArticleIdList></Reference><Reference><Citation>Maloney JA, et al. MRI findings in children with acute flaccid paralysis and cranial nerve dysfunction occurring during the 2014 enterovirus D68 outbreak. Am J Neuroradiol. 2015;36(2):245&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7965662</ArticleId><ArticleId IdType="pubmed">25414005</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, et al. A mouse model of enterovirus D68 infection for assessment of the efficacy of inactivated vaccine. Viruses. 2018;10:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5850365</ArticleId><ArticleId IdType="pubmed">29385753</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, et al. Enterovirus D68 virus-like particles expressed in Pichia pastoris potently induce neutralizing antibody responses and confer protection against lethal viral infection in mice. Emerg Microbes Infect. 2018;7(1):3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5837163</ArticleId><ArticleId IdType="pubmed">29323105</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014;370(9):829&#x2013;837.</Citation><ArticleIdList><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, et al. Dynamic profiles of neutralizing antibody responses elicited in rhesus monkeys immunized with a combined tetravalent DTaP-Sabin IPV candidate vaccine. Vaccine. 2014;32(9):1100&#x2013;1106.</Citation><ArticleIdList><ArticleId IdType="pubmed">24412578</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, et al. Immune serum from sabin inactivated poliovirus vaccine immunization neutralizes multiple individual wild and vaccine-derived polioviruses. Clin Infect Dis. 2017;64(10):1317&#x2013;1325.</Citation><ArticleIdList><ArticleId IdType="pubmed">28419204</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry Dunand CJ, et al. Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection. Cell Host Microbe. 2016;19(6):800&#x2013;813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4901526</ArticleId><ArticleId IdType="pubmed">27281570</ArticleId></ArticleIdList></Reference><Reference><Citation>Howell KA, et al. Cooperativity enables non-neutralizing antibodies to neutralize ebolavirus. Cell Rep. 2017;19(2):413&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6082427</ArticleId><ArticleId IdType="pubmed">28402862</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutsvunguma LZ, et al. Identification of multiple potent neutralizing and non-neutralizing antibodies against Epstein-Barr virus gp350 protein with potential for clinical application and as reagents for mapping immunodominant epitopes. Virology. 2019;536:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6733660</ArticleId><ArticleId IdType="pubmed">31377598</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray K, et al. Concurrent exposure of neutralizing and non-neutralizing epitopes on a single HIV-1 envelope structure. Front Immunol. 2019;10:1512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6628914</ArticleId><ArticleId IdType="pubmed">31338095</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H, et al. A novel neutralizing antibody specific to the DE loop of VP1 can inhibit EV-D68 infection in mice. J Immunol. 2018;201(9):2557&#x2013;2569.</Citation><ArticleIdList><ArticleId IdType="pubmed">30282753</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong C, et al. Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys. Vaccine. 2011;29(37):6269&#x2013;6275.</Citation><ArticleIdList><ArticleId IdType="pubmed">21722686</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai W, et al. A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in mice. Vaccine. 2018;36(5):653&#x2013;659.</Citation><ArticleIdList><ArticleId IdType="pubmed">29295756</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, et al. Structure and inhibition of EV-D68, a virus that causes respiratory illness in children. Science. 2015;347(6217):71&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4307789</ArticleId><ArticleId IdType="pubmed">25554786</ArticleId></ArticleIdList></Reference><Reference><Citation>Bootz A, et al. Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus. PLoS Pathog. 2017;13(8):e1006601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5595347</ArticleId><ArticleId IdType="pubmed">28854233</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens DM, Folkers GK, Fauci AS. Acute flaccid myelitis: something old and something new. MBio. 2019;10:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6445942</ArticleId><ArticleId IdType="pubmed">30940708</ArticleId></ArticleIdList></Reference><Reference><Citation>Montes M, et al. Enterovirus D68 causing acute respiratory infection: clinical characteristics and differences with acute respiratory infections associated with enterovirus non-D68. Pediatr Infect Dis J. 2019;38(7):687&#x2013;691.</Citation><ArticleIdList><ArticleId IdType="pubmed">30985516</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrinelli L, et al (2019) Epidemiologic and molecular study of EVs in hospitalized children with severe acute respiratory infection. Pediatr Infect Dis J</Citation><ArticleIdList><ArticleId IdType="pubmed">31469780</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CY, et al. The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus. PLoS One. 2019;14(1):e0210553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6334917</ArticleId><ArticleId IdType="pubmed">30650163</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, et al. A broadly cross-protective vaccine presenting the neighboring epitopes within the VP1 GH loop and VP2 EF loop of enterovirus 71. Sci Rep. 2015;5:12973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525384</ArticleId><ArticleId IdType="pubmed">26243660</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, et al. Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16. Vaccine. 2013;31(17):2130&#x2013;2136.</Citation><ArticleIdList><ArticleId IdType="pubmed">23499595</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbaghi A, et al. Inactivation methods for whole influenza vaccine production. Rev Med Virol. 2019;20:e2074.</Citation><ArticleIdList><ArticleId IdType="pubmed">31334909</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim EH, Han GY, Nguyen H. An adenovirus-vectored influenza vaccine induces durable cross-protective hemagglutinin stalk antibody responses in mice. Viruses. 2017;9:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5580491</ArticleId><ArticleId IdType="pubmed">28825679</ArticleId></ArticleIdList></Reference><Reference><Citation>van Schooten J, van Gils MJ. HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth. Retrovirology. 2018;15(1):74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6260891</ArticleId><ArticleId IdType="pubmed">30477581</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong R, et al. Antibody lineages with vaccine-induced antigen-binding hotspots develop broad HIV neutralization. Cell. 2019;178(3):567.e19&#x2013;584.e19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6755680</ArticleId><ArticleId IdType="pubmed">31348886</ArticleId></ArticleIdList></Reference><Reference><Citation>Moodie Z, et al. Neutralizing antibody correlates analysis of tetravalent dengue vaccine efficacy trials in Asia and Latin America. J Infect Dis. 2018;217(5):742&#x2013;753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5854020</ArticleId><ArticleId IdType="pubmed">29194547</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaid DJ, et al. Heritability of vaccine-induced measles neutralizing antibody titers. Vaccine. 2017;35(10):1390&#x2013;1394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5548390</ArticleId><ArticleId IdType="pubmed">28189400</ArticleId></ArticleIdList></Reference><Reference><Citation>Tambyah PA, et al. An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: a phase I, double blind, randomized, placebo-controlled, study of two dosages. Vaccine. 2019;37(31):4344&#x2013;4353.</Citation><ArticleIdList><ArticleId IdType="pubmed">31230881</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, et al. Study of the integrated immune response induced by an inactivated EV71 vaccine. PLoS One. 2013;8(1):e54451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3553120</ArticleId><ArticleId IdType="pubmed">23372725</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku Z, et al. Single neutralizing monoclonal antibodies targeting the VP1 GH loop of enterovirus 71 inhibit both virus attachment and internalization during viral entry. J Virol. 2015;89(23):12084&#x2013;12095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4645313</ArticleId><ArticleId IdType="pubmed">26401034</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B, et al. A bispecific broadly neutralizing antibody against enterovirus 71 and coxsackievirus A16 with therapeutic potential. Antiviral Res. 2019;161:28&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">30419253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichiyoshi Y, Casali P. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J Exp Med. 1994;180(3):885&#x2013;895.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2191637</ArticleId><ArticleId IdType="pubmed">8064239</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng W, et al. Efficient generation of monoclonal antibodies from single rhesus macaque antibody secreting cells. MAbs. 2015;7(4):707&#x2013;718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4622687</ArticleId><ArticleId IdType="pubmed">25996084</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittle JR, et al. Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages. J Virol. 2014;88(8):4047&#x2013;4057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3993745</ArticleId><ArticleId IdType="pubmed">24501410</ArticleId></ArticleIdList></Reference><Reference><Citation>Mankowski MC, et al. Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms. Proc Natl Acad Sci U S A. 2018;115(1):E82&#x2013;E91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5776832</ArticleId><ArticleId IdType="pubmed">29255018</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang KA, et al. Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans. Nat Microbiol. 2019;4(2):306&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">30478290</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbaghi A, et al. Inactivation methods for whole influenza vaccine production. Rev Med Virol. 2019;29(6):e2074.</Citation><ArticleIdList><ArticleId IdType="pubmed">31334909</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilton T, et al. Effect of formaldehyde inactivation on poliovirus. J Virol. 2014;88(20):11955&#x2013;11964.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4178759</ArticleId><ArticleId IdType="pubmed">25100844</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Q, et al. Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization. Nat Microbiol. 2019;4(1):124&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6727974</ArticleId><ArticleId IdType="pubmed">30397341</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>